From: Jamie Kelly [jkelly@BridgeMedical.com]
Sent: Monday, June 16, 2003 11:15 AM
To: 'fdadockets@oc.fda.gov'
Subject: RE: 2000N-0204 - Bar Code Label for Human Drug Products and
Blood ; Proposed Rule

Could you kindly confirm that the FDA rule commentary that I sent to this
address on Friday, June 13, 2003 at 3:08 PM PST will be posted rather than
the message I sent in error at 2:35 PM on that same day?

I appreciate your response. 

Jamie Kelly
Director of Marketing

Bridge Medical, Inc.
An AmerisourceBergen Company
120 South Sierra Ave
Solana Beach, CA 92075
858.314.5619
jkelly@bridgemedical.com

>  -----Original Message-----
> From: 	Jamie Kelly  
> Sent:	Friday, June 13, 2003 3:09 PM
> To:	'fdadockets@oc.fda.gov'
> Subject:	2000N-0204 - Bar Code Label for Human Drug Products and
> Blood; Proposed Rule
> 
> 
> 	My apologies.  Please disregard the eariler correspondence sent at
> 2:35 PM.  The attachment was incomplete.
> 
> 	Please find attached the public commentary of Bridge Medical, Inc.,
> an AmerisourceBergen Company, in regards to 
> 	21 CFR Parts 201, 606, and 610 - Bar Code Label for Human Drug
> Products and Blood; Proposed Rule.
> 
> 	 << File: Bridge Medical Response to FDA Proposed Rule due.doc >> 
> 	Jamie Kelly
> 	Director of Marketing
> 
> 	Bridge Medical, Inc.
> 	An AmerisourceBergen Company
> 	120 South Sierra Ave
> 	Solana Beach, CA 92075
> 	858.314.5619
> 	jkelly@bridgemedical.com
>